Treating octogenarian and nonagenarian acute myeloid leukemia patients—Predictive prognostic models
Authors:
Open Access
Abstract
BACKGROUND: Treating the octogenarian and nonagenarian patients who have acute myeloid leukemia (AML) with intensive chemotherapy is controversial. Several models to predict outcome were proposed, including the use of a comorbidity index. However, it is unclear whether the Charlson comorbidity index (CCI) or the hematopoietic cell transplant comorbidity index (HCTCI) is more sensitive. METHODS: The authors analyzed their experience with 92 patients aged ≥80 years who had AML. Patients' pretreatment characteristics and their treatment outcomes were recorded. RESULTS: All patients were offered intensive treatment; 59 patients (64%) were treated intensively with a variety of regimens, whereas 33 patients (36%) elected to receive supportive care. The CCI and the HCTCI had similar predictive ability for outcome in both groups. A multivariate analyses of prognostic factors identified near‐normal albumin (48% of patients; 1‐year survival rate, >27%) as a favorable factor for the whole cohort, age 25%) and nonmonocytic morphology (75% of patients; 1‐year survival rate, >26%) as favorable factors for the intensively treated cohort, and bone marrow blasts 19%) as a favorable factor for patients who received supportive care. CONCLUSIONS: This retrospective analysis was developed to assist in treatment decisions for octogenarian and nonagenarian patients with AML. The findings will need validation in a prospective study. Cancer 2009. © 2009 American Cancer Society.Keywords
This publication has 36 references indexed in Scilit:
- Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaHaematologica, 2008
- Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemiaCancer, 2007
- Treatment of acute myeloid leukemia patients aged more than 75 years: Results of the E-AML-01 trial of the Japanese Elderly Leukemia and Lymphoma Study Group (JELLSG)Leukemia & Lymphoma, 2006
- Differences in Outcome in Adolescents With Acute Lymphoblastic Leukemia: A Consequence of Better Regimens? Better Doctors? Both?Journal of Clinical Oncology, 2003
- Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood, 2002
- Treatment of newly‐diagnosed acute myelogenous leukaemia in patients aged 80 years and aboveBritish Journal of Haematology, 1996
- The management of acute myelogenous leukemia in the elderly: Ten‐year experience in 118 patientsHematological Oncology, 1992
- Acute myeloid leukemia in elderly adultsHematological Oncology, 1990
- Impact of Advanced Age on the Management of Acute Nonlymphocytic Leukemia: A Study of 103 PatientsActa Haematologica, 1990
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987